BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33538529)

  • 1. Pleural Drainage Strategy After IPC Placement: A Focused Clinical Review.
    Gilbert CR; Miller RJ
    J Bronchology Interv Pulmonol; 2021 Apr; 28(2):160-167. PubMed ID: 33538529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
    Davies HE; Mishra EK; Kahan BC; Wrightson JM; Stanton AE; Guhan A; Davies CW; Grayez J; Harrison R; Prasad A; Crosthwaite N; Lee YC; Davies RJ; Miller RF; Rahman NM
    JAMA; 2012 Jun; 307(22):2383-9. PubMed ID: 22610520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of indwelling pleural catheters for the treatment of malignant pleural effusions.
    Syer T; Walker S; Maskell N
    Expert Rev Respir Med; 2019 Jul; 13(7):659-664. PubMed ID: 31177915
    [No Abstract]   [Full Text] [Related]  

  • 5. Indwelling Pleural Catheter Drainage Strategy for Malignant Effusion: A Cost-Effectiveness Analysis.
    Shafiq M; Simkovich S; Hossen S; Feller-Kopman DJ
    Ann Am Thorac Soc; 2020 Jun; 17(6):746-753. PubMed ID: 32125880
    [No Abstract]   [Full Text] [Related]  

  • 6. Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.
    Fysh ET; Thomas R; Read CA; Kwan BC; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DC; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YC
    BMJ Open; 2014 Nov; 4(11):e006757. PubMed ID: 25377015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
    Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
    Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.
    Penz ED; Mishra EK; Davies HE; Manns BJ; Miller RF; Rahman NM
    Chest; 2014 Oct; 146(4):991-1000. PubMed ID: 24832000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial.
    Bhatnagar R; Kahan BC; Morley AJ; Keenan EK; Miller RF; Rahman NM; Maskell NA
    Trials; 2015 Feb; 16():48. PubMed ID: 25880969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis.
    Srour N; Amjadi K; Forster A; Aaron S
    Can Respir J; 2013; 20(2):106-10. PubMed ID: 23616967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
    Yeung M; Loh EW; Tiong TY; Tam KW
    Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
    Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
    BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver Nitrate-coated versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial.
    Shrager JB; Bhatnagar R; Kearney CT; Retzlaff NP; Cohen E; Stanton AE; Keyes C; Wahidi MM; Gillespie C; Rahman N; Kerry AL; Feller-Kopman D; Nader D; Akulian J; Chen A; Berry M; Majid A; Reddy C; Tremblay A; Maskell NA
    Ann Am Thorac Soc; 2022 Oct; 19(10):1722-1729. PubMed ID: 35363591
    [No Abstract]   [Full Text] [Related]  

  • 14. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
    Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
    Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions.
    Asciak R; Hallifax RJ; Mercer RM; Hassan M; Wigston C; Wrightson JM; Psallidas I; Rahman NM
    Respiration; 2019; 97(1):70-77. PubMed ID: 30227409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
    Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
    BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
    Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
    Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.
    Iyer NP; Reddy CB; Wahidi MM; Lewis SZ; Diekemper RL; Feller-Kopman D; Gould MK; Balekian AA
    Ann Am Thorac Soc; 2019 Jan; 16(1):124-131. PubMed ID: 30272486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
    Olfert JA; Penz ED; Manns BJ; Mishra EK; Davies HE; Miller RF; Luengo-Fernandez R; Gao S; Rahman NM
    Respirology; 2017 May; 22(4):764-770. PubMed ID: 27983774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling pleural catheters in non-small cell lung cancer patients with malignant pleural effusions.
    Wang M; Sparrow K; Chan C; Gillson A; Stollery D; Li P
    Respir Med; 2023 Jan; 206():107093. PubMed ID: 36549515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.